Dr. James Anderson received his Ph.D. at Oregon State University in 1967. In 1976, he graduated from the Case Western Reserve University School of Medicine with an M.D. degree and finished his Anatomic Pathology residency at the Institute of Pathology of University Hospitals of Cleveland in 1979. Following the completion of his residency, Dr. Anderson joined the faculty of the Institute of Pathology at Case Western Reserve University. Dr. Anderson has worked in the area of biomaterials, medical devices, and prostheses for the past 40 years and his current activities range from the clinical pathology evaluation of retrieved implants from humans to fundamental studies of cellular interactions with biomaterials.
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at the cause of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialization of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialization and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialization of human organs using graphene-based nanocomposite materials and stem cells technology.
Debora is a doctor and CEO of the Iberoamerican Institute of Bioregenerative Medicine (IBIOMER). She has been working with autologous stem cell transplants from bone marrow (BMSC) in humans for 5 years. Her research focuses on clinically correlating the angioplastic and immunoregulatory power of autologous BMSC transplants without culture in patients with endothelial dysfunction/inflammation as in diabetes mellitus. These present reduction of circulating endothelial progenitor cells which preceding macro and microvascular complications and autonomic or somatic neuropathic damage. Their study, under multidisciplinary management of clinical cases of diabetic foot with perforating lesions to states of necrosis grade III / IV, reached, as a result, the total regeneration of tissues, 30 days after the first autotransplant with previous physiological conditioning in vivo, to promove the angiogenic activation. She works hard to promote to IBIOMER and the translational research in Venezuela with multicenter studies to extend other Latinoamerican countries.
Mohamed Abd Ellatif Mohamed Said completed his studies at Mansoura University (1985-1995), Toronto University (2001). Then he went back to Mansoura University and joined as a Professor in Medical Biochemistry and Molecular Biology, Faculty of Medicine. In 2007 he joined as a professor of Clinical Biochemistry and Molecular Biology, College of Medicine, King Khalid University, Kingdom of Saudi Arabia during the period from 2/9/2007 till now. He has more than 55 research papers in national and international journals. He attended more than 43 international and national workshops and conferences. He is an active reviewer for many scientific journals and conferences. He handled 8 master thesis and 7 Ph.D. thesis.
Majid Ghassemi is a Professor of Mechanical Engineering Department at the K. N. Toosi University of Technology in Tehran, Iran. He has over 20 years of academic and industrial experience and served as the President of the K. N. Toosi University of Technology from 2010 through 2013. Professor Ghassemi has also served in several public and private boards and panels and supervised several undergraduate, masters and PhD students, published several books and many journal and conference papers. He is currently Editor-in-Chief and Editorial Board member for many international journals. He also serves as member in several international conferences. Professor Ghassemi received his Ph.D. in Mechanical Engineering from Iowa State University in 1993.
Biomaterials, Regenerative Medicine, Tissue Engineering and Nanomedicine
Dr. Gilson Khang was born in 1960 in South Korea (55 years old), where he obtained his degrees at the Inha Univ (B.S. and M.S.). In 1987, he joined the Dr Hai Bang Lee’s Biomaterials Lab at Korea Research Institute of Chemical Technology (KRICT, Deajeon, Korea). He was studying for Ph.D. degree at the Department of Biomedical Engineering, The Univ of Iowa (Iowa City, IA, USA) from 1991~1995 under the guidance of Prof Joon B. Park. For 11 years (1987~1998) at KRICT, he worked on the development of drug delivery systems, the contact lens, blood bag, blood-compatible vascular graft, urinary catheter and tissue engineered cartilage, bone and spinal cord. His academic career started at the Department of PolymerNano Science and Technology at Chonbuk National University (CBNU, Assistant Professor, 1998-2004; Associate Professor, 2004-2009) and then tenured by Full Professor in 2009. He was planning and steering over 10 big grants from 1998 to present for the Korean Government, for example, Development of Drug Delivery System for Anticancer Drug (2MUSD/yr for 5 years, Korean Ministry of Intellectual and Economy), Stem Cell Research Center (10MUSD/yr for 10 years, Korea Ministry of Education, Science & Technology), Muscloskeletal Bioorgan Center (1MUSD/yr for 9 years, Korea Ministry of Health & Welfare) and so on. From 2006 to 2011, he was the PI of BK-21 (Brain Korea 21 Project) and WCU (World Class University, 3MUD/yr for 5 years) Program at CBNU supported by KMEST. He was Chair Professor in the Department of BIN Fusion Technology of WCU program of CBNU.
Tissue engineering, Mesenchaymal stem cell, and Drug delivery system
Pathology and Stem cells
Prof. Andrzej Lange, MD, FRCP graduated with a medical degree with distinction from the Medical School in Wroc?aw, Poland is a professor in the Institute of Immunology and Exp Therapy of the Polish Academy of Sciences and a founder and head of the Lower Silesian Center of Cellular Transplantation in Wroc?aw. His international experience started in 1973 – 1974 as a Leverhulme Fellow in the Middlesex Hospital Medical School, London. He has been a visitor and lectured in a number of European and North American scientific institutions. Known from his activity in the field of bone marrow transplantation and regenerative medicine. Prof. Lange was awarded several scientific distinctions and served to a number of National and European institutions were also active in co-editing journals. He is an author and co-author of 249 scientific papers, in peer-reviewed journals with a cumulative IF of 270 in the years 1995–2017